NAT2 and larynx cancer: In a recent study on the Turkish population, the slow acetylator NAT2*7 allele was correlated to a reduced UADT cancer risk [191] as well as larynx cancer [192], thus suggesting a protective role of NAT2*7 genotype in HNC.